Northwestern Ophthalmic Institute S.C. Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2006
NCT00675207
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (3)

brimonidine (alphagan) (1 trial)

brinzolamide (azopt) (1 trial)

dorzolamide (trusopt) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glaucoma (Phase 4)

Glaucoma, Open-Angle (Phase 4)

Hypertension (Phase 4)

Ocular Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3